Video

Other Emerging Treatment Modalities in Cutaneous Squamous Cell Carcinoma

Author(s):

Nikhil Kushalani, MD,Martin Dietrich, MD, PhD, Florida Cancer Specialists & Research Institute

Shared insight on novel treatment modalities in the setting of cutaneous squamous cell carcinoma and how they may be triaged moving forward.

Related Videos
4 experts are featured in this series.
4 experts are featured in this series.
Related Content
This week’s top 5 includes a snapshot of FDA approvals from December, an exclusive roundup of critical NCCN guideline updates from 2024, and more.
January 4th 2025

The OncFive: Top Oncology Articles for the Week of 12/29

Yvonne Mowery, MD, PhD, physician scientist, associate professor, radiation oncology, University of Pittsburgh Medical Center Hillman Cancer Center
January 7th 2025

Pembrolizumab Plus Preoperative Radiotherapy and Surgery Improves DFS in Soft-Tissue Sarcoma: With Yvonne Mowery, MD, PhD

Lynn M. Schuchter, MD
January 1st 2025

A 30-Year Commitment to Advancing Melanoma Care

Onyee Chan, MD, hematologist/oncologist, Moffitt Cancer Center Magnolia Campus; Bradley D. Hunter, MD, medical director, Oncology, director, Immune Effector Cell Therapy, Intermountain Healthcare
December 24th 2024

Asciminib and Ponatinib Sit at the Forefront of Advances in CML Management: Insights From Onyee Chan, MD; and Bradley D. Hunter, MD

OncLive’s December Roundup of Key FDA Approvals in Oncology
December 30th 2024

OncLive’s December Roundup of Key FDA Approvals in Oncology

Omid Hamid, MD
December 25th 2024

Novel Therapies and Combinations Augment Melanoma Treatment Arsenal